PubMed=18922971; DOI=10.1158/1541-7786.MCR-08-0166
Yu E.J., Lee Y., Rha S.Y., Kim T.S., Chung H.C., Oh B.K., Yang W.I., Noh S.H., Jeung H.-C.
Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma.
Mol. Cancer Res. 6:1554-1566(2008)

PubMed=18804159; DOI=10.1016/j.ygeno.2008.08.002
Jung J.-J., Jeung H.-C., Chung H.C., Lee J.O., Kim T.S., Kim Y.T., Noh S.H., Rha S.Y.
In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Genomics 93:52-61(2009)

DOI=10.1158/1538-7445.AM2016-139
Kim T.S., Park K.H., Kwon W.S., Lee W.S., Jeong I., Kang S.K., Kim H.M., Rha S.Y., Chung H.C.
Novel gastric cancer cell lines established from diffuse type gastric cancer patients for potential subgroup-specific therapy.
Cancer Res. 76 Suppl. 14:139-139(2016)

PubMed=29435981; DOI=10.1002/ijc.31304
Kim H.J., Kang S.K., Kwon W.S., Kim T.S., Jeong I., Jeung H.-C., Kragh M., Horak I.D., Chung H.C., Rha S.Y.
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
Int. J. Cancer 143:151-159(2018)